Malignant Hyperthermia

Czech version

Authors: I. Schröderová ¹; P. Nohel ¹; D. Štěpánková ²
Authors‘ workplace: ARK, FN u sv. Anny v Brně, Pekařská 53, 656 91 Brno 2ARO a ECMO centrum FN Brno, pracoviště Dětská nemocnice ¹
Published in: Anest. intenziv. Med., , 2004, č. 3, s. 130-139
Category:

Overview

Malignant hyperthermia is a serious complication of general anaesthesia. It is a genetically determined disposition with anautosomal dominant transfer. The development of MH is conditioned by the exposure to triggering agents – inhalationanaesthetics and suxamethonium.The nature ofMHis a disorder of calcium metabolismin sarcoplasmic reticulum receptorsin skeletal muscle. The review presents an overview of the history and current knowledge of pathophysiology, genetics,clinical picture and treatment of MH, gives important information for anaesthesia practice, summarizes current means ofpre-symptomatic testing and informs on the state of MH diagnostics world-wide and in the Czech Republic.

Key words:
malignant hyperthermia – pre-symptomatic diagnostics – National Center for Diagnostics of MalignantHyperthermia in the Czech Republic

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Anaesthesiology, Resuscitation and Inten Intensive Care Medicine

The Role of the Anaesthesiologist, His Work and Responsibility during the Surgery: A PreoperativeSurvey on Patients’ Opinions, Attitudes and Notions

Mechanical Ventilation at Paediatric Intensive Care Units

Levosimendan and its Role in the Management of Heart Failure

The History of Resuscitation III.(From the 19th century to the beginning of the 20th century)

Article was published in

Anaesthesiology and Intensive Care Medicine

2004 Issue 3